Dr. Yakubov celebrates professional excellence in the fields of molecular cell biology and synthetic mRNA technology.

Clinicians Urged to Not Withhold COVID-19 Vaccinations from Pregnant Patients, Provide Counseling on Side Effects, Support those Who Choose Not to be Vaccinated.

Dr. Smith wants people to value education, creativity and service

The License provides EYAM with the exclusive right to develop several proprietary COVID-19 vaccine candidates in a self-amplifying mRNA vaccine platform. EYAM anticipates rapid commencement of animal trials for these COVID-19 vaccine candidates.

Dr. Samir Arora, President & Medical Director will lead the Aventiv Research study program.

New York City's SB Capital Management Inc. has expanded both its investment portfolio and its charitable efforts in light of COVID-19, strategizing for long-term growth and strong returns.

Dr. Sykes channels decades of professional knowledge into his current work with the University at Buffalo

Dr. Thach is celebrating 47 years at Washington University

Dr. Kole is credited with discovery of exon-skipping technology, building Ercole Biotech, a research stage biopharmaceutical company, and contributions to development of Eteplirsen (Exondys 51), a drug for treatment of Duchenne muscular dystrophy

5th Annual Traumatic Brain Injury Conference - April 15, 16, 2015 Washington, DC